2025-05-12 01:25:10, GGRNA : RefSeq release 60 (20130726)
LOCUS NM_001185117 3517 bp mRNA linear PRI 24-JUN-2013 DEFINITION Homo sapiens claudin 19 (CLDN19), transcript variant 3, mRNA. ACCESSION NM_001185117 VERSION NM_001185117.1 GI:297515501 KEYWORDS RefSeq. SOURCE Homo sapiens (human) ORGANISM Homo sapiens Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo. REFERENCE 1 (bases 1 to 3517) AUTHORS Al-Shibli,A., Konrad,M., Altay,W., Al Masri,O., Al-Gazali,L. and Al Attrach,I. TITLE Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC): report of three cases with a novel mutation in CLDN19 gene JOURNAL Saudi J Kidney Dis Transpl 24 (2), 338-344 (2013) PUBMED 23538362 REMARK GeneRIF: Case Reports: novel CLDN19 mutation in familial hypomagnesemia with hypercalciuria and nephrocalcinosis. REFERENCE 2 (bases 1 to 3517) AUTHORS Godron,A., Harambat,J., Boccio,V., Mensire,A., May,A., Rigothier,C., Couzi,L., Barrou,B., Godin,M., Chauveau,D., Faguer,S., Vallet,M., Cochat,P., Eckart,P., Guest,G., Guigonis,V., Houillier,P., Blanchard,A., Jeunemaitre,X. and Vargas-Poussou,R. TITLE Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: phenotype-genotype correlation and outcome in 32 patients with CLDN16 or CLDN19 mutations JOURNAL Clin J Am Soc Nephrol 7 (5), 801-809 (2012) PUBMED 22422540 REMARK GeneRIF: The risk of end-stage renal disease in patients with CLDN19 mutations was two times the risk of patients with CLDN16 mutations. Ocular abnormalities were observed only in patients with CLDN19 mutations. REFERENCE 3 (bases 1 to 3517) AUTHORS Ekinci,Z., Karabas,L. and Konrad,M. TITLE Hypomagnesemia-hypercalciuria-nephrocalcinosis and ocular findings: a new claudin-19 mutation JOURNAL Turk. J. Pediatr. 54 (2), 168-170 (2012) PUBMED 22734304 REMARK GeneRIF: In a patient with consanguineous parents, history of disturbed organization and development of the retina, a diagnosis of Familial hypomagnesemia with hypercalciuria and nephrocalcinosis caused by claudin-19 mutation should be considered. REFERENCE 4 (bases 1 to 3517) AUTHORS Faguer,S., Chauveau,D., Cintas,P., Tack,I., Cointault,O., Rostaing,L., Vargas-Poussou,R. and Ribes,D. TITLE Renal, ocular, and neuromuscular involvements in patients with CLDN19 mutations JOURNAL Clin J Am Soc Nephrol 6 (2), 355-360 (2011) PUBMED 21030577 REMARK GeneRIF: Ocular manifestations and exercise intolerance mimicking mild to moderate periodic paralysis are two symptoms that may occur in patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis and may indicate CLDN19 mutations. REFERENCE 5 (bases 1 to 3517) AUTHORS Lal-Nag,M. and Morin,P.J. TITLE The claudins JOURNAL Genome Biol. 10 (8), 235 (2009) PUBMED 19706201 REMARK Review article REFERENCE 6 (bases 1 to 3517) AUTHORS Gonzalez-Mariscal,L., Betanzos,A., Nava,P. and Jaramillo,B.E. TITLE Tight junction proteins JOURNAL Prog. Biophys. Mol. Biol. 81 (1), 1-44 (2003) PUBMED 12475568 REMARK Review article REFERENCE 7 (bases 1 to 3517) AUTHORS Tsukita,S. and Furuse,M. TITLE Claudin-based barrier in simple and stratified cellular sheets JOURNAL Curr. Opin. Cell Biol. 14 (5), 531-536 (2002) PUBMED 12231346 REMARK Review article REFERENCE 8 (bases 1 to 3517) AUTHORS Tsukita,S., Furuse,M. and Itoh,M. TITLE Multifunctional strands in tight junctions JOURNAL Nat. Rev. Mol. Cell Biol. 2 (4), 285-293 (2001) PUBMED 11283726 REMARK Review article REFERENCE 9 (bases 1 to 3517) AUTHORS Heiskala,M., Peterson,P.A. and Yang,Y. TITLE The roles of claudin superfamily proteins in paracellular transport JOURNAL Traffic 2 (2), 93-98 (2001) PUBMED 11247307 REMARK Review article REFERENCE 10 (bases 1 to 3517) AUTHORS Kniesel,U. and Wolburg,H. TITLE Tight junctions of the blood-brain barrier JOURNAL Cell. Mol. Neurobiol. 20 (1), 57-76 (2000) PUBMED 10690502 REMARK Review article COMMENT REVIEWED REFSEQ: This record has been curated by NCBI staff. The reference sequence was derived from AK096063.1, AK298992.1 and AC098484.2. Summary: The product of this gene belongs to the claudin family. It plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity. Defects in this gene are the cause of hypomagnesemia renal with ocular involvement (HOMGO). HOMGO is a progressive renal disease characterized by primary renal magnesium wasting with hypomagnesemia, hypercalciuria and nephrocalcinosis associated with severe ocular abnormalities such as bilateral chorioretinal scars, macular colobomata, significant myopia and nystagmus. Alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jun 2010]. Transcript Variant: This variant (3) lacks an exon in the CDS, which results in frame-shift, and contains an additional segment in the 3' region compared to variant 1. The resulting isoform (c) is shorter and has a distinct C-terminus compared to isoform a. Sequence Note: This RefSeq record was created from transcript and genomic sequence data to make the sequence consistent with the reference genome assembly. The genomic coordinates used for the transcript record were based on transcript alignments. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications. ##Evidence-Data-START## Transcript exon combination :: AK298992.1 [ECO:0000332] ##Evidence-Data-END## PRIMARY REFSEQ_SPAN PRIMARY_IDENTIFIER PRIMARY_SPAN COMP 1-24 AK096063.1 1-24 25-746 AK298992.1 4-725 747-1586 AC098484.2 83002-83841 c 1587-3517 AC098484.2 81071-83001 c FEATURES Location/Qualifiers source 1..3517 /organism="Homo sapiens" /mol_type="mRNA" /db_xref="taxon:9606" /chromosome="1" /map="1p34.2" gene 1..3517 /gene="CLDN19" /gene_synonym="HOMG5" /note="claudin 19" /db_xref="GeneID:149461" /db_xref="HGNC:2040" /db_xref="MIM:610036" exon 1..414 /gene="CLDN19" /gene_synonym="HOMG5" /inference="alignment:Splign:1.39.8" CDS 192..848 /gene="CLDN19" /gene_synonym="HOMG5" /note="isoform c is encoded by transcript variant 3; claudin-19" /codon_start=1 /product="claudin-19 isoform c" /protein_id="NP_001172046.1" /db_xref="GI:297515502" /db_xref="CCDS:CCDS53306.1" /db_xref="GeneID:149461" /db_xref="HGNC:2040" /db_xref="MIM:610036" /translation="
MANSGLQLLGYFLALGGWVGIIASTALPQWKQSSYAGDAIITAVGLYEGLWMSCASQSTGQVQCKLYDSLLALDGHIQSARALMVVAVLLGFVAMVLSVVGMKCTRVGDSNPIAKGRVAIAGGALFILAGMNLAQPCSWAGPQLAWPCWAAPSSAAHARSQRDPTAAHSPIGLDPLLLPESTSELRLPWPAPHPVAPLPSIQPASQHPGQGHWGIGWA
" misc_feature 201..>515 /gene="CLDN19" /gene_synonym="HOMG5" /note="PMP-22/EMP/MP20/Claudin family; Region: PMP22_Claudin; cl15797" /db_xref="CDD:210197" exon 415..579 /gene="CLDN19" /gene_synonym="HOMG5" /inference="alignment:Splign:1.39.8" variation 468 /gene="CLDN19" /gene_synonym="HOMG5" /replace="a" /replace="g" /db_xref="dbSNP:34374110" exon 580..3517 /gene="CLDN19" /gene_synonym="HOMG5" /inference="alignment:Splign:1.39.8" ORIGIN
attctggagtccagagccactgcctttgctccagccgctgccgccgcaccacctctccttctctgcctctgaccctccttctcgctgctccccctgcccagctgctcctcccacctggccatgaccaaagcccctgctggcaccctggcccagctctgagtcctgggaccctcggtcctctctcctgggccatggccaactcaggcctccagctcctgggctacttcttggccctgggtggctgggtgggcatcattgctagcacagccctgccacagtggaagcagtcttcctacgcaggcgacgccatcatcactgccgtgggcctctatgaagggctctggatgtcctgcgcctcccagagcactgggcaagtgcagtgcaagctctacgactcgctgctcgccctggacggtcacatccaatcagcgcgggccctgatggtggtggccgtgctcctgggcttcgtggccatggtcctcagcgtagttggcatgaagtgtacgcgggtgggagacagcaaccccattgccaagggccgtgttgccatcgccgggggagccctcttcatcctggcaggtatgaatttggcccagccctgttcgtgggctgggcctcagctggcctggccgtgctgggcggctccttcctctgctgcacatgcccggagccagagagacccaacagcagcccacagccctatcggcctggaccctctgctgctgcccgagagtacgtctgagctccgcctgccctggccagccccccacccagtggcccccttgcccagcatccagccagcctcgcagcaccctgggcagggccactggggcataggatgggcataggtgctctgagcagcttgtcctcaacacaagcacccaccctgcaatctgagacccagatcctcagagagacaccagaggcaggacccagcccccaggcatacacacagatgcaggtccaggcacggtcttgtctgcacagcctggtgggcaccagcatgcatccctggagacaggccctcaggcaccagcccggctgtttactcactgaagagctgcttgggtgtctgctacgtgctgggccctagagatagagcagtggccaagacgtaccttagtacccaggtccttggggtgagcagaaaccttcaccctccccagtcccatgggctcctcacagcaaccccacaagggcagtgccgggatgctgaacgttcacacaaggacagggagggtctgagtttaggtctcaggttcttccagtgcgcccagggctgggggccacctacacagatggtgaggtcggaccatggcgcccctgcccccgggaatgggccccaggcagggctgctgtgagggccaaggtctggccacgctggccagtacccatgtccgggcctgaatgcacagcccctgcccccgaccccacagctcactccactaaccagctctctctcttttgactttcagaccagttgttaaattgcccgcctccgccaagggccccctgggtgtgtaatgtccagtccccagccaggctctgtcccctgccatacctagactgtgtgtttcatatttttttggaaagagaagtgaacatccagccccaatcatggtatcattcggtctgtcctcagcgtggcttggacggggcctgtgtcagagtggtcagtgctgacccctggggctcttgggcagaaagatgaggagacagaggtccagggtgggttacatagcacatccagggctaagcaagaaataattcagaggtcctaccctctgtctagggacccccctcccaagcctggccttggccttggcacaaagtcctccttgataggagatcccactcactcctggaggctgcccctgaggcttggcccagctctaggagcagtccccagggtcagggagcccctggtgtggaaagaggccccaaggtagtaaaccctgcccctgttactgtgctccagagacctcctaagggaagggacagttcctggaaggccctccagctggatgctggggatcagcgataggtgaggggacacagtgtaggagctccccatgtagaaaagggaatgtggggagggcgttaggagcttgcaggcattaggactgtcctgagcaaggtctgcagcccccagctctgctcaccccgaatcctgccccttgtttccacacctaccattcctcctctcctgatccccagcatccagctgaggtccaaggtctttgtcctagaatcagagtggggaggggacagcctggggctgcccagagactgtgggtggagctgcctgctgcactcagcagtgcggtcagagaagggcttttggtcttgaagtccaggtaccatccccccttagcatacagggggaagggcctgagaggaatgtaaggaaaccagcccagatcagtcccaaggccagagtcctttgtcctacatctccctgaaccagagtgtgccctgcccctcatgctcagacctctcccaccccaaaccctctcccgggactcagtctccctggccactgcgtatcaggcttctggggaaagcatccatcacagaacctccccttccctgccacgcaccttccttggccagctccattctggcctcctccaccacctgccttgtgaccacatctcccaccacgtccccagatctcaagaacgcagctcagcttctccttcgagcttgactctgagagggaaagtgacggaaaccaagtcagatgagatgactgccatgtacactgcagtcaagggcagggaggggaggaatgacacaaatggcagggagctgctgggggactgacccctcggcgcctggcctggccggtgctgcacatccaccggggcacaacagggacttgtccagcctctggtcagaggatgtggccacctgaccctaaataggttccccagagtcctgcccctctaatgaatgagaactgcaggagtttctcctctgggtgcctgaagctatagtgcaatggttcccaaccctgcatgcacattcgaatcacctgggggcacaatgcctaggctccaaccccagacactcttatttcattggtctgggtggacctggcatcagaagtcatgtagctcctcaggggactgtagtgtgtggtcagcactgagggctcctctatgaggcctcaagcccaggtgactctgtgaggtctgcagagggagaaaagaacccacaagggaagaggtggaggtcaggcacggtggctcacgcttgtaatcccagcactttgggaggccgaggtgggtagatacctgaagtcaggagttcgagactagcctggccaatatggtaaaaccccgtgtctattaaaaatacaaaaattagctggctgtggtggtgggcacctgtaatcccagctactcgggaggctgaggcaggagaatcgcttgaactcgggaggtggaggttgcagtcagccaagatcgtgccactgcacaccatcctggatgacagagcaagactccatcac
//
ANNOTATIONS from NCBI Entrez Gene (20130726): GeneID:149461 -> Molecular function: GO:0005198 [structural molecule activity] evidence: IEA GeneID:149461 -> Molecular function: GO:0042802 [identical protein binding] evidence: ISS GeneID:149461 -> Biological process: GO:0007601 [visual perception] evidence: IEA GeneID:149461 -> Biological process: GO:0016338 [calcium-independent cell-cell adhesion] evidence: ISS GeneID:149461 -> Biological process: GO:0019227 [neuronal action potential propagation] evidence: IEA GeneID:149461 -> Biological process: GO:0043297 [apical junction assembly] evidence: IEA GeneID:149461 -> Biological process: GO:0050896 [response to stimulus] evidence: IEA GeneID:149461 -> Cellular component: GO:0005634 [nucleus] evidence: IEA GeneID:149461 -> Cellular component: GO:0005737 [cytoplasm] evidence: IEA GeneID:149461 -> Cellular component: GO:0005923 [tight junction] evidence: IDA GeneID:149461 -> Cellular component: GO:0005923 [tight junction] evidence: ISS GeneID:149461 -> Cellular component: GO:0016021 [integral to membrane] evidence: IEA GeneID:149461 -> Cellular component: GO:0016323 [basolateral plasma membrane] evidence: IDA GeneID:149461 -> Cellular component: GO:0043296 [apical junction complex] evidence: IDA
by
@meso_cacase at
DBCLS
This page is licensed under a Creative Commons Attribution 2.1 Japan License.